Table 2.

Secondary transplantation of BM reconstituted with SP- or MP-CD34-KSL cells



Primary Tx

Secondary Tx
Cell type
Total
Total
Myeloid
B lymphoid
T lymphoid
SP-CD34-KSL      
   Recipient 1   64.1   13.4 ± 4.3   2.8 ± 1.6   10.2 ± 5.0   29.7 ± 9.6  
   Recipient 2   53.2   59.1 ± 11.6   54.5 ± 21.5   87.1 ± 6.89   48.8 ± 19.1  
MP-CD34-KSL      
   Recipient 1   55.9   27.6 ± 14.3   2.4 ± 2.0   40.6 ± 24.2   40.4 ± 19.8  
   Recipient 2
 
50.5
 
6.1 ± 1.7
 
0.9 ± 0.9
 
3.8 ± 4.8
 
6.2 ± 2.6
 


Primary Tx

Secondary Tx
Cell type
Total
Total
Myeloid
B lymphoid
T lymphoid
SP-CD34-KSL      
   Recipient 1   64.1   13.4 ± 4.3   2.8 ± 1.6   10.2 ± 5.0   29.7 ± 9.6  
   Recipient 2   53.2   59.1 ± 11.6   54.5 ± 21.5   87.1 ± 6.89   48.8 ± 19.1  
MP-CD34-KSL      
   Recipient 1   55.9   27.6 ± 14.3   2.4 ± 2.0   40.6 ± 24.2   40.4 ± 19.8  
   Recipient 2
 
50.5
 
6.1 ± 1.7
 
0.9 ± 0.9
 
3.8 ± 4.8
 
6.2 ± 2.6
 

Four months after primary transplantation, 2 × 106 BM cells from 2 recipient mice reconstituted with 30 SP-CD34-KSL cells and from 2 recipient mice reconstituted with 30 MP-CD34-KSL cells (Table 1) were transplanted into irradiated mice

Secondary recipient mice were analyzed 4 months after transplantation. The percent chimerism is shown as mean ± SD for total leukocytes, myeloid cells, B-lymphoid cells, and T-lymphoid cells. For the secondary recipients of the first mouse of each cell type, n = 9; for those of the second, n = 10

Tx indicates transplantation

or Create an Account

Close Modal
Close Modal